Standalone figures · ₹ crore · years without a filed annual are summed from quarters
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 238 | 344 | 364 | 462 | 414 | 399 | 596 | 501 | 495 | 597 | 871 | |
| COGS | -21 | -49 | -214 | 271 | 244 | 218 | 373 | 353 | 334 | 352 | 634 |
| Gross profit | — | — | — | 191 | 170 | 181 | 224 | 149 | 161 | 245 | 238 |
| 233 | 333 | 504 | 66 | 72 | 78 | 108 | 94 | 118 | 161 | 145 | |
| 26 | 61 | 74 | 125 | 98 | 103 | 116 | 55 | 44 | 84 | 93 | |
| OPM % | 10.9% | 17.8% | 20.4% | 27% | 23.6% | 25.9% | 19.4% | 10.9% | 8.8% | 14.1% | 10.7% |
| Depreciation | 3 | 3 | 19 | 22 | 23 | 26 | 29 | 34 | 32 | 31 | 32 |
| Interest | 1 | 1 | 6 | 4 | 2 | 1 | 1 | 3 | 1 | 2 | 2 |
| 2 | 8 | 10 | 5 | 6 | 4 | 9 | 4 | 17 | 7 | 9 | |
| Profit before tax | 24 | 65 | 59 | 104 | 79 | 81 | 95 | 21 | 27 | 58 | 68 |
| Tax | 8 | 21 | 20 | 33 | 13 | 18 | 25 | 6 | 8 | 15 | 18 |
| Tax % | 35.5% | 33% | 34.6% | 31.4% | 16.2% | 22.7% | 25.9% | 27.4% | 28.3% | 26.8% | 25.9% |
| 15 | 44 | 39 | 72 | 66 | 62 | 71 | 15 | 20 | 42 | 50 | |
| PAT margin % | 6.4% | 12.6% | 10.6% | 15.5% | 15.9% | 15.7% | 11.8% | 3% | 4% | 7.1% | 5.8% |
| EPS (₹) | 19.3 | 44.1 | 22.4 | 32.7 | 15.1 | 14.3 | 16.2 | 3.5 | 4.5 | 9.7 | 11.5 |
| EPS adjusted (₹) | — | 13.7 | 12.2 | 16.4 | 15.1 | 14.3 | 16.2 | 3.5 | 4.5 | 9.7 | 11.5 |
| 26% | 11.3% | 24.5% | 14.9% | 19.9% | 24.5% | 24.8% | 29% | 22.2% | 15.5% | 21.7% | |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 8 | 8 | 11 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 15 | 287 | 331 | 380 | 430 | 485 | 483 | 498 | 535 | 579 |
| 9 | 82 | 24 | 21 | 27 | 18 | 37 | 38 | 32 | 8 | |
| 21 | 118 | 101 | 103 | 91 | 111 | 87 | 116 | 137 | 141 | |
| Total equity & liabilities | 53 | 495 | 467 | 526 | 570 | 636 | 628 | 673 | 727 | 750 |
| — | 297 | 285 | 329 | 318 | 392 | 363 | 345 | 347 | 344 | |
| CWIP | — | 4 | 15 | 18 | 45 | 0 | 8 | 17 | 11 | 17 |
| Investments | — | 1 | 10 | 0 | 6 | 10 | 16 | 27 | 24 | 26 |
| 53 | 192 | 157 | 179 | 201 | 234 | 241 | 284 | 345 | 364 | |
| Total assets | 53 | 495 | 467 | 526 | 570 | 636 | 628 | 673 | 727 | 750 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Chemical | 829.56 | 69.26 | 533.66 | 91.79 | 441.87 | 15.67 |
| Solar Power | 26.86 | 11.57 |
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 40 | 137 | 59 | 62 | 85 | 13 | 34 | 53 | 102 | |
| -171 | 31 | -50 | -45 | -44 | -55 | -26 | -32 | -39 | -37 | |
| 124 | -77 | -88 | -10 | -8 | -26 | -1 | -5 | -16 | -62 | |
| Net cash flow | — | — | — | — | 10 | 4 | -15 | -3 | -2 | 3 |
| Free cash flow | — | — | — | — | 23 | 27 | -1 | 7 | 28 | 68 |
| CFO / Operating profit % | 91.4% | 53.4% | 109.7% | 60.2% | 60.5% | 73.2% | 23.6% | 77.2% | 62.7% | 109.9% |
| 104.5 |
| 5.75 |
| 98.75 |
| 11.72 |
| Others | 10.82 | 1.26 | 18.56 | 11.57 | 6.99 | 18.03 |
| Pharma | 4.2 | -5.49 | 13.96 | 9.78 | 4.18 | -131.34 |
₹ crore by fiscal year